REGN - Regeneron high-dose Eylea gains FDA approval
2023-08-18 21:10:28 ET
More on Regeneron
- Regeneron could see share price bounce with potential approvals
- Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening
- Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront
- Regeneron: Eylea Hype Past, But '23 H2 Will Be A Gut Check
For further details see:
Regeneron high-dose Eylea gains FDA approval